Evidence map›Paper›PMID 8150009›Full record

ArticleEpidemiology and infection1994

Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk.

I Nachamkin, S H Fischer, X H Yang, O Benitez, A Cravioto

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

I NachamkinDepartment of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-4283.
S H Fischer
X H Yang
O Benitez
A Cravioto
University of Pennsylvania · USUniversidad Nacional Autónoma de México · MX

Funding

IMMUNOBIOLOGY OF CAMPYLOBACTER JEJUNIR01AI024122 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI NACHAMKIN, IRVING · 1988 to 1990
–
NIAID NIH HHS AI-24122
6 · The paper itself

Abstract

We studied the relationship between IgA anti-campylobacter flagellin antibodies in breast milk samples and protection of breastfed infants living in a rural Mexican village from campylobacter infection. There were fewer episodes of campylobacter infection (symptomatic and asymptomatic combined) in infants breastfed with milk containing specific anti-flagellin antibodies (1.2/child/year, 95% CI 0.6-1.8) versus non-breastfed children (3.3/child/year, 95% CI 1.8-4.8; P < 0.01). Infants breastfed with milk that was anti-flagellin antibody negative by ELISA also had fewer episodes of infection compared with non-breastfed children, but the difference did not reach statistical significance (1.8/child/year, 95% CI 0.7-3.0 versus 3.3/child/year, 95% CI 1.8-4.8, P > 0.05). Breastfeeding has a protective effect against campylobacter infection and is associated with the presence of specific antibodies directed against campylobacter flagellin.

Indexed as

Breast FeedingAnalysis of VarianceAntibodies, BacterialCampylobacter InfectionsCampylobacter jejuniConfidence IntervalsDiarrhea, InfantileEnzyme-Linked Immunosorbent AssayFecesFlagellinHumansImmunoglobulin AInfantInfant, NewbornMexicoMilk, HumanAntibodies, BacterialFlagellinImmunoglobulin AAge FactorsAmericasAntibodies--analysisBacterial And Fungal Diseases--prevention and controlBiologyBreast FeedingDemographic FactorsDeveloping CountriesDiseasesHealthHuman MilkImmunityImmunologic FactorsInfantInfant NutritionInfectionsLactationLatin AmericaMaternal PhysiologyMexicoNorth AmericaNutritionPhysiologyPopulationPopulation CharacteristicsResearch ReportYouth

Identifiers

PMID8150009
PMCPMC2271450
OpenAlexW2052700952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.